The federal contract IDV award SPE2D225D0002 is a single-award Indefinite Delivery Contract awarded to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The $8,147,325.32 contract provides a national supply source for the Defense Logistics Agency (DLA), Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons to procure various pharmaceutical and medical products, including generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and sulfamethoxazole-trimethoprim. The contract has a base period of one year with four one-year option periods, allowing these federal agencies to issue task and delivery orders for specific products on an as-needed basis to support their respective healthcare missions.
The contract originated from a pre-solicitation notice issued by the DLA for a national requirements contract for Atenolol Tablets. The solicitation will be for Atenolol 25 MG, 50 MG, and 100 MG tablets in 90 and 1000 count bottles. This will be an unrestricted commercial item acquisition under FAR Part 12, with no small business set-asides. The contract will utilize a firm-fixed price with requirements structure to provide these Atenolol products to the DoD, VA, IHS, and Bureau of Prisons through the DLA and VA prime vendor programs.
Generated 4/1/25, 12:43 AM